Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada
P. Wals, G. Deceuninck, {. Boucher, и M. Ouakki. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 46 (8):
e75--77(апреля 2008)PMID: 18444843.
DOI: 10.1086/533469
Аннотация
To assess the risk of Guillain-Barré syndrome (GBS) following administration of meningococcal serogroup C-CRM(197) conjugate vaccine, provincial immunization records were linked with hospital discharge records, and medical charts were reviewed. In the cohort of 1.9 million individuals (age, 2 months to 20 years), observed postvaccination frequencies of GBS were not higher than expected.
%0 Journal Article
%1 de_wals_risk_2008
%A Wals, Philippe De
%A Deceuninck, Geneviève
%A Boucher, Renée-Myriam
%A Ouakki, Manale
%D 2008
%J Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
%K Adolescent, Adult, Child, Cohort Humans, Infant, Meningococcal Preschool, Quebec Studies, Syndrome, Vaccines, {Guillain-Barre}
%N 8
%P e75--77
%R 10.1086/533469
%T Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada
%U http://www.ncbi.nlm.nih.gov/pubmed/18444843
%V 46
%X To assess the risk of Guillain-Barré syndrome (GBS) following administration of meningococcal serogroup C-CRM(197) conjugate vaccine, provincial immunization records were linked with hospital discharge records, and medical charts were reviewed. In the cohort of 1.9 million individuals (age, 2 months to 20 years), observed postvaccination frequencies of GBS were not higher than expected.
@article{de_wals_risk_2008,
abstract = {To assess the risk of {Guillain-Barré} syndrome {(GBS)} following administration of meningococcal serogroup {C-CRM(197)} conjugate vaccine, provincial immunization records were linked with hospital discharge records, and medical charts were reviewed. In the cohort of 1.9 million individuals (age, 2 months to 20 years), observed postvaccination frequencies of {GBS} were not higher than expected.},
added-at = {2011-03-11T10:05:34.000+0100},
author = {Wals, Philippe De and Deceuninck, Geneviève and Boucher, {Renée-Myriam} and Ouakki, Manale},
biburl = {https://www.bibsonomy.org/bibtex/28125aeea1eb23824838d5485f665e4fc/jelias},
doi = {10.1086/533469},
interhash = {36d32c6225ea95552cbefe6cbd4aa5d5},
intrahash = {8125aeea1eb23824838d5485f665e4fc},
issn = {1537-6591},
journal = {Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America},
keywords = {Adolescent, Adult, Child, Cohort Humans, Infant, Meningococcal Preschool, Quebec Studies, Syndrome, Vaccines, {Guillain-Barre}},
month = apr,
note = {{PMID:} 18444843},
number = 8,
pages = {e75--77},
timestamp = {2011-03-11T10:06:37.000+0100},
title = {Risk of {Guillain-Barré} syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada},
url = {http://www.ncbi.nlm.nih.gov/pubmed/18444843},
volume = 46,
year = 2008
}